PARP-1 Inhibitor, DPQ, Attenuates LPS-Induced Acute Lung Injury through Inhibiting NF-κB-Mediated Inflammatory Response

Open Access

Peer-reviewed

Research Article

Gang Wang,

Affiliation College of Veterinary Medicine, Northwest Agriculture & Forestry University, Yangling, Shaanxi, China
⨯
Xiaojia Huang,

Affiliation Department of Pharmacology, School of Medical Sciences and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu, China
⨯
Yongjin Li,

Affiliation Department of Pharmacology, School of Medical Sciences and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu, China
⨯
Kangkang Guo,

Affiliation College of Veterinary Medicine, Northwest Agriculture & Forestry University, Yangling, Shaanxi, China
⨯
Pengbo Ning,

Affiliation College of Veterinary Medicine, Northwest Agriculture & Forestry University, Yangling, Shaanxi, China
⨯
Yanming Zhang

* E-mail: zhangym@nwsuaf.edu.cn

Affiliation College of Veterinary Medicine, Northwest Agriculture & Forestry University, Yangling, Shaanxi, China
⨯

Reader Comments (0)

Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Cytokine therapy
Is the Subject Area "Cytokine therapy" applicable to this article?

Thanks for your feedback.